ss

Christine Liu

Partner

Foreign Legal Consultant (Hong Kong)

Co-head, White Collar Crime & Investigations, Life Sciences Sector

DLA Piper is one of our panel firms dedicated to investigating some of the more difficult cases in the market, including matters involving alleged commercial misconduct across various regions and government inquiries. They are robust in the way they conduct cases, able to tackle larger issues with a well-sized team and handle matters efficiently. Christine Liu is tenacious and hardworking – we can rely on her findings.
— Client, GIR 100 2025
Hong KongShanghai

About

Christine focuses her practice on government and internal investigations, regulatory enforcement, and compliance matters. As the co-leader of the White-collar Crime and Investigations practice for the firm's Life Sciences Sector, she brings extensive experience in guiding multinational companies through complex legal and regulatory challenges.

Christine has led internal and government-facing investigations across Asia, including mainland China, Hong Kong, Taiwan, India, the Philippines, Malaysia, and Singapore. She possesses deep expertise in investigations and compliance for multinational pharmaceutical, medical device, and healthcare companies operating in the Greater China region.

She regularly advises clients on matters involving the U.S. Foreign Corrupt Practices Act (FCPA), financial fraud, conflict of interest, internal controls, and other white-collar crimes. Additionally, she provides guidance on risk assessments, compliance programs, due diligence for mergers and acquisitions, and internal training.

Christine has represented clients across a broad array of industries, including life sciences, healthcare, consumer goods, industrials, technology, manufacturing, automotive, energy and natural resources.

Areas of FocusLitigation, Arbitration and InvestigationsRegulatory and Government AffairsData, Privacy and CybersecurityConsumer Goods, Food and RetailHealthcareIndustrialsLife SciencesTechnology

EXPERIENCE

Corporate Investigations

  • Acted for a global technology company in multiple internal investigations across India and China, and a self-disclosure to the U.S. DOJ and SEC regarding alleged FCPA violations.
  • Represented a multinational pharmaceutical company in an SEC investigation concerning potential FCPA violations in Malaysia.
  • Advised a global life sciences company on an internal investigation into alleged FCPA violations in India.
  • Represented a U.S. pharmaceutical company in a joint SEC and DOJ investigation into alleged FCPA misconduct in China.
  • Advised a global technology company in responding to a Congressional investigation in the Philippines.
  • Represented a global consumer goods company in multiple China-based internal investigations involving allegations of financial fraud, embezzlement, and employee misconduct.
  • Led a high-stakes internal investigation for a global medical device company concerning potential violations of Chinese criminal codes.
  • Conducted multiple internal investigations for a global industrial company into senior management conflicts of interest and supply chain corruption.
  • Represented a global industrial company in an internal investigation regarding alleged Russia sanctions violations.

Compliance and Due Diligence

  • Guided a global biopharma company in developing and implementing compliance programs across multiple Asian jurisdictions.
  • Assisted a global manufacturing company with pre-acquisition anti-corruption due diligence throughout Asia.
  • Advised a multinational automotive company on enhancing internal controls and compliance programs.
  • Provided compliance and anti-corruption training to a global energy company, tailoring programs to regional risks and regulatory requirements.
Languages
  • English
  • Chinese (Mandarin)

Awards

  • Hong Kong Law Society Pro Bono and Community Service Individual Bronze Award (2021)
  • Hong Kong Law Society Pro Bono and Community Service Individual Bronze Award (2020)
  • Special Award of the 2018-2020 Recognition Scheme for Provision of Pro Bono Legal Services, Chief Secretary for Administration, HKSAR
Education
  • South Texas College of Law Houston, J.D., Magna Cum Laude
  • East China Normal University, B.A., M.A.

Seminars

  • FCPA update and impact to Chinese companies and multinational companies doing business in China, 4th Compliance Management and Practice Conference, June 19-21, 2025
  • Navigating the next phase of US-China trade relations, co-hosted by Control Risks and DLA Piper, January 17, 2025
  • Shaping the Future: Technology in Compliance and Investigations, 16th Asia Anti-corruption Compliance Hong Kong Summit, November 20, 2024
  • The US-China Business Council (USCBC) Legal and Regulatory Event Series: Anti-Corruption Compliance Webinar, October 23, 2024

Admission and Certificate

  • Foreign Legal Consultant (Texas, USA) in Hong Kong
  • Texas, USA

Memberships And Affiliations

  • The State Bar of Texas
  • The Law Society of Hong Kong

My latest insights

Publication

Global Enforcement Trends & Bribery Offenses Guide 2025

3 de novembro de 2025

Publication

Global enforcement trends: What global corporates need to know

3 de novembro de 2025

Publication

China releases first-of-its-kind compliance case handbook for life sciences companies

16 de julho de 2025 .67 minute read

View All
CallvCardLinkedInPrint

Connect

Phone

+852 2103 0668
(Work, Hong Kong)
+86 21 3852 2111
(Work, Shanghai)